Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
about
Cocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?The influence of dehydration on the prognosis of acute ischemic stroke for patients treated with tissue plasminogen activator.Amelioration of Cerebral Ischemic Injury by a Synthetic Seco-nucleoside LMT497.Thrombosis: Novel nanomedical concepts of diagnosis and treatmentActive Compounds of Rhubarb Root and Rhizome in Animal Model Experiments of Focal Cerebral IschemiaSynthesis and Characterization of Tissue Plasminogen Activator-Functionalized Superparamagnetic Iron Oxide Nanoparticles for Targeted Fibrin Clot DissolutionA literature review of cost-effectiveness of intravenous recombinant tissue plasminogen activator for treating acute ischemic stroke.Utility of perfusion imaging in acute stroke treatment: a systematic review and meta-analysis.Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.Endothelial precursor cells stimulate pericyte-like coverage of bone marrow-derived mesenchymal stem cells through platelet-derived growth factor-BB induction, which is enhanced by substance P.TRPM7 is a unique target for therapeutic intervention of stroke.Update on the effects of treatment with recombinant tissue-type plasminogen activator (rt-PA) in acute ischemic stroke.The Phenolic Components of Gastrodia elata improve Prognosis in Rats after Cerebral Ischemia/Reperfusion by Enhancing the Endogenous Antioxidant Mechanisms.HDAC4 in ischemic stroke: mechanisms and therapeutic potential
P2860
Q28077232-C286EE36-F245-44F0-8ABD-8A0C95BE2842Q33795876-6D313AEA-CE85-4D62-B104-43F397A94753Q35187249-FBE2C267-AEC0-485E-8C6F-246640ADB74CQ35996696-1946CA28-E283-4D78-BDFE-34C97881A99EQ36162885-C931D8E2-DE8A-4707-85CF-11F57A7796F5Q38637802-CB26AFAC-F0B4-4ADA-B58E-C3A5D7804474Q38665544-6FB07137-D11F-4211-BF37-242D095BCE4FQ40044797-E3DBD5BB-157C-42D7-B593-37C6D665DC3DQ41929851-6B7CDDC7-F531-4DD6-8A93-436C682DCA0DQ47343852-86EB85C2-BD4B-4FFD-B2FE-15B2A1E5571FQ47815763-46A65C77-71B0-4C1D-AB23-F56921CBC3ADQ47852921-E2447067-B498-4FFB-9A13-FFE9A76E6F89Q48558308-43FE3BD2-1966-4BD4-B030-76B2D6E97195Q55253857-96A85506-8711-44CE-AAFF-7F57F1EAE61BQ58747047-B2838921-6158-4522-B9C0-25D6A25FE905
P2860
Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Current perspectives on the us ...... tment of acute ischemic stroke
@ast
Current perspectives on the us ...... tment of acute ischemic stroke
@en
type
label
Current perspectives on the us ...... tment of acute ischemic stroke
@ast
Current perspectives on the us ...... tment of acute ischemic stroke
@en
prefLabel
Current perspectives on the us ...... tment of acute ischemic stroke
@ast
Current perspectives on the us ...... tment of acute ischemic stroke
@en
P2093
P2860
P921
P356
P1476
Current perspectives on the us ...... tment of acute ischemic stroke
@en
P2093
Andrew M Southerland
Karen C Johnston
Prachi Mehndiratta
Sherita N Chapman
Timothy L McMurry
P2860
P356
10.2147/VHRM.S39213
P407
P5008
P577
2014-02-24T00:00:00Z